1746-29-8Relevant academic research and scientific papers
Compound, liquid crystal composition, liquid crystal display element and liquid crystal display
-
Paragraph 0150; 0152-0154, (2020/02/27)
The present invention relates to a compound, a liquid crystal composition, a liquid crystal display element, and a liquid crystal display. The compound is a compound represented by a formula I shown in the description. The liquid crystal composition of the present invention contains the compound represented by the formula I. The compound represented by the formula I has the advantages of good mutual solubility with other compounds and good UV resistance. As a reactive mesogen (RM), the compound has the advantages of good mutual solubility, high polymerization activity (less monomer residue), and strong binding ability. The compound can not only be used as a self-aligning agent for the liquid crystal compositions alone, but also can be used as a vertical alignment material for copolymerization with other RMs so as to be used as a self-aligning agent for the liquid crystal compositions in a PSA (polymer-supported alignment) and PS (polymer-stabilized) mode, the PI preparation process canbe avoided, the preparation process of the liquid crystal display element or liquid crystal display can be simplified, and the production efficiency can be improved.
Compounds, liquid crystal composition, liquid crystal display element and liquid crystal display
-
Paragraph 0168; 0170; 0171; 0172, (2020/02/27)
The invention relates to compounds, a liquid crystal composition, a liquid crystal display element and a liquid crystal display. The compounds are represented by a formula I shown in the description.The liquid crystal composition provided by the invention
Phenylethylamine analogs and their use for treating glaucoma
-
Page/Page column 9, (2010/11/26)
Phenylethylamine analogs useful for treating glaucoma are disclosed.
